Columnist Kristin Neva shares what she feels has worked and not worked in terms of slowing her husband's ALS progression over 15 years.

The ongoing EAP that is providing ALS patients with access to MN-166 (ibudilast) outside of a clinical trial is adding more sites.

Daily treatment with IPL344 for up to three years was safe and slowed ALS progression in a small Phase 2a clinical trial, data showed.

The number of people living with amyotrophic lateral sclerosis (ALS) in the U.S. is expected to steadily climb — by more than 10% — over this decade, increasing from an estimated 32,800 cases in 2022 ...

Exercise may have many benefits for ALS patients, including reducing depression and improving strength and stamina. But it must be performed carefully to be beneficial. Patients should work with a ...

There is currently no cure for amyotrophic lateral sclerosis (ALS), but there are a number of treatments that can delay the progression of symptoms. There are also a number of experimental treatments ...

The FDA granted orphan drug designation to ketamine, PharmaTher's investigational therapy for the treatment of amyotrophic lateral sclerosis.

Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease characterized by the progressive loss of motor neurons, nerve cells that control the voluntary muscles. This leads to overall ...

Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease characterized by the progressive loss of motor neurons, nerve cells that control the voluntary muscles. This leads to symptoms ...

Ionis Pharmaceuticals is opening a Phase 3 safety and efficacy trial of ION363 (jacifusen) in amyotrophic lateral sclerosis (ALS) patients with confirmed mutations in the FUS gene, a known cause of ...

Learn more about the prevalence, incidence and etiology of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.

Read about a study highlighting evidence in support of using Cannabis-derived compounds (cannabinoids) as an optional treatment for patients with ALS.